Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
1. LLY stock surged from $360 to $960 in 2023-2024. 2. Earnings of $6.31 per share beat estimates of $5.60. 3. Zepbound faces growth headwinds, impacting future sales. 4. Upcoming earnings on Oct. 30 are highly anticipated. 5. LLY has seen technical performance lag behind S&P 500.